The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Role of biologic therapy in the treatment of unresectable appendiceal epithelial neoplasms (AEN).
Cathy Eng
No relevant relationships to disclose
Michael J. Overman
Research Funding - Amgen; Roche/Genentech
Keith F. Fournier
No relevant relationships to disclose
Richard E. Royal
No relevant relationships to disclose
Aki Ohinata
No relevant relationships to disclose
Safia Rafeeq
No relevant relationships to disclose
Jonathan Phillips
No relevant relationships to disclose
Robert A. Wolff
No relevant relationships to disclose
Paul F. Mansfield
No relevant relationships to disclose